Skip to main content
AAPA 2025 Annual Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Invitation Only
Invitation Only
Ticketed - Complimentary
Ticketed - Complimentary
Ticketed - Additional Fee Required
Ticketed - Additional Fee Required
Capturing for On Demand
Capturing for On Demand
Pharmacology
Pharmacology
National Health Priorities
National Health Priorities
Potential State Requirement
Potential State Requirement
Project Innovation
Project Innovation
PA Administrative Competencies
PA Administrative Competencies
Back

ENDO-Endocrinology

DIVR-Disparities/Diversity

Foundations of Gender-affirming Hormone Therapy: Treatment Initiation and Management

Saturday, May 17, 2025
10:30 AM – 11:30 AM  
Location: Colorado Convention Center, Room 401
CE: 1.00 AAPA Category 1 CME
Capturing for On Demand Pharmacology

  • Joanne Rolls, MPAS, MEHP, PA-C (she/her/hers)

    Vice-Chair of Education for the PA Education and Sciences Division and Director of Didactic Education University of Utah PA Program
    University of Utah School of Medicine
    Salt Lake City, UT, United States

Transgender and gender-diverse people are an increasingly visible and vibrant part of our population and communities. These populations have historically had inadequate access to primary and gender-affirming care. Providing affirming healthcare, including gender-affirming hormone therapy, is an important way to improve care, access, and outcomes for this population. PAs in primary and specialty care are well poised to improve access to therapeutic care for this population, and all PAs can benefit from being familiar with the foundations of gender-affirming hormone therapy. Participants will leave this session able to utilize the most current guidelines for initiating gender-affirming hormone therapy for transgender and gender non-binary adult patients. Attendees will also be able to adjust pharmacologic care, monitor appropriate labs, manage more complex cases, and navigate appropriate referrals.

Learning Objectives:

At the conclusion of this session, participants should be able to:
  • Obtain a gender-inclusive and professional medical, surgical, and social history, including collecting Sexual Orientation and Gender Identity (SOGI) data
  • Describe the range of non-pharmacologic treatment approaches for transgender and gender non-binary people
  • Initiate, titrate, monitor, and manage evidence-based and appropriate gender-affirming pharmacologic treatments for transgender and gender non-binary adults
  • Select appropriate laboratory testing, modify treatment regimens, and identify complications for transgender and gender non-binary adults, and refer as appropriate